Author

E. G. Barrett

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Werts· 2 shared H. Irshad· 2 shared P. J. Kuehl· 2 shared S. N. Langel· 2 shared A. D. Werts· 1 shared A. M. Healy· 1 shared A. R. Charbit· 1 shared C. I. Martinez· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Werts

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters

P. J. Kuehl, J. Dearing, A. Werts, J. Cox, H. Irshad, E. G. Barrett, S. Tucker, S. N. Langel

This paper designs and validates an exposure system for efficient SARS-CoV-2 airborne transmission in Syrian hamsters, showing similar virological outcomes between 1:1 and 1:4 infected-to-naive ratios.

bioRxiv · Nov 18, 2022Microbiology

Oral and intranasal Ad5 SARS-CoV-2 vaccines decrease disease and viral transmission in a golden hamster model

S. N. Langel, S. Johnson, C. I. Martinez, S. N. Tedjakusuma, N. Peinovich, E. G. Dora, P. J. Kuehl, H. Irshad, E. G. Barrett, A. Werts, S. N. Tucker

This study shows oral and intranasal Ad5 SARS-CoV-2 vaccines reduce disease severity and viral transmission in golden hamsters.

bioRxiv · Oct 3, 2021Immunology

Thiol drugs decrease SARS-CoV-2 lung injury in vivo and disrupt SARS-CoV-2 spike complex binding to ACE-2 in vitro

K. Khanna, W. Raymond, J. Jin, A. R. Charbit, I. Gitlin, M. Tang, A. D. Werts, E. G. Barrett, J. M. Cox, S. M. Birch, R. Martinelli, H. S. Sperber, S. Franz, S. Pillai, A. M. Healy, , J. V. Fahy

Thiol drugs inhibit SARS-CoV-2 infection in vitro and reduce lung injury in vivo, supporting their potential as COVID-19 treatments.

bioRxiv · Dec 8, 2020 · PreprintMicrobiology